EUR/USD
1.13894
-0.292%
Gold
3983.14
-0.832%
Oil
70.011
-0.376%
USD/JPY
162.187
0.157%
GBP/USD
1.32310
-0.199%
GBP/JPY
214.595
-0.034%
Real-time News
Japans construction orders fell 6.7% year-on-year in May, compared with a previous reading of -32.3%.Japans housing starts rose 33.9% year-on-year in May, below the expected 31.80% and the previous months 11.40%.June 30th - Prices surged due to the Iranian situation, quickly giving back as markets anticipate the resumption of previously disrupted Middle Eastern supplies. Aluminum prices are on track for their biggest monthly drop since 2008, having plummeted over 15% so far in June. The temporary ceasefire agreement between the US and Iran fueled optimism, with markets expecting the reopening of the Strait of Hormuz to resume freight transport in the Middle East. This expectation erased gains from the previous three months. Like other metals, aluminum prices have also been impacted by the rapid strengthening of the US dollar since mid-May, making dollar-denominated metals more expensive for most buyers. Furthermore, market expectations that the Federal Reserve will need to maintain high interest rates for an extended period, and may even raise rates further to curb inflation, have also weighed on the demand outlook.On June 30th, the National Energy Administration released the "China Power Supply Development Report 2026." The report shows that my country has built the worlds largest power supply system, forming a world-class mega-power supply service network covering both urban and rural areas. The report indicates that by 2025, my countrys total electricity consumption will reach a new milestone, exceeding 10 trillion kilowatt-hours, with nearly 800 million electricity users, leading the world in user volume. There are also 99,000 power supply service outlets nationwide, employing over 560,000 people, propelling my countrys power supply capacity and service level into the ranks of the worlds top tier.On June 30, Eli Lilly and Innovent Biologics (01801.HK) jointly announced that they have reached a cooperation agreement regarding the rights to Eli Lillys CDK4&6 inhibitor Vizzar® (abecicalbide tablets) in mainland China: Innovent Biologics will be responsible for the import, sales, promotion and distribution of Vizzar® (abecicalbide tablets) in mainland China; Eli Lilly will continue to be responsible for the production, supply and ongoing development of the product.
